A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Phase 3 Recruiting
440 enrolled
A Study of Daratumumab
Phase 3 Recruiting
500 enrolled
CERVINO
Phase 3 Recruiting
380 enrolled
MonumenTAL-6
Phase 3 Recruiting
795 enrolled
MK-2870-009
Phase 3 Recruiting
520 enrolled
TroFuse-022
Phase 3 Recruiting
770 enrolled
MajesTEC-7
Phase 3 Recruiting
1,590 enrolled
SUCCESSOR-1
Phase 3 Recruiting
810 enrolled
OMAHA-003
Phase 3 Recruiting
1,310 enrolled
MK-5684-004
Phase 3 Recruiting
1,314 enrolled
MagnetisMM-6
Phase 3 Recruiting
1,116 enrolled
Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma
Phase 3 Recruiting
180 enrolled
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 Recruiting
288 enrolled
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 Recruiting
1,450 enrolled
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 Recruiting
228 enrolled
BRAINS
Phase 3 Recruiting
408 enrolled
OLYMPIA-4
Phase 3 Recruiting
216 enrolled
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Phase 3 Recruiting
492 enrolled
MAGNETISMM-5
Phase 3 Recruiting
944 enrolled
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 Recruiting
411 enrolled
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Phase 3 Recruiting
292 enrolled
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Phase 3 Recruiting
1,000 enrolled
CHORD
Phase 3 Recruiting
182 enrolled
DREAMM-10
Phase 3 Recruiting
520 enrolled
CAMS-Ph+ B-ALL
Phase 3 Recruiting
150 enrolled
FUMANBA-03
Phase 3 Recruiting
240 enrolled
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Phase 3 Recruiting
510 enrolled
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 Recruiting
5,000 enrolled
LBL 2018
Phase 3 Recruiting
683 enrolled
FREEDOM
Phase 3 Recruiting
318 enrolled
HL-Russia-1
Phase 3 Recruiting
300 enrolled
HOVON174MM
Phase 3 Recruiting
599 enrolled
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Phase 3 Recruiting
376 enrolled
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)
Phase 3 Recruiting
406 enrolled